These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 27004407)

  • 41. Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition.
    Deng Y; Li F; He P; Yang Y; Yang J; Zhang Y; Liu J; Tong Y; Li Q; Mei X; Shu Z; Zhao Q
    Mol Carcinog; 2018 Jun; 57(6):807-814. PubMed ID: 29500880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
    Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
    PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Let-7b-5p promotes triptolide-induced growth-inhibiting effects in glioma by targeting IGF1R.
    Liu X; Zhao P; Du X; Hou J; Zhang G; Zhang W; Yang L; Chen Y
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5909-5925. PubMed ID: 38363352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gossypol has anti-cancer effects by dual-targeting MDM2 and VEGF in human breast cancer.
    Xiong J; Li J; Yang Q; Wang J; Su T; Zhou S
    Breast Cancer Res; 2017 Mar; 19(1):27. PubMed ID: 28274247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical and computational evaluation of Triptolide-induced cytotoxicity against NSCLC.
    Hamdi AM; Jiang ZZ; Guerram M; Yousef BA; Hassan HM; Ling JW; Zhang LY
    Biomed Pharmacother; 2018 Jul; 103():1557-1566. PubMed ID: 29864943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance.
    Li M; Zhang X; Zhou WJ; Chen YH; Liu H; Liu L; Yang CM; Qan WB
    Acta Pharmacol Sin; 2013 Dec; 34(12):1545-53. PubMed ID: 24241349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
    Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
    Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis.
    Ben Yebdri F; Van Grevenynghe J; Tang VA; Goulet ML; Wu JH; Stojdl DF; Hiscott J; Lin R
    Mol Ther; 2013 Nov; 21(11):2043-53. PubMed ID: 23985699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.
    Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L
    Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway.
    Kim MJ; Lee TH; Kim SH; Choi YJ; Heo J; Kim YH
    Int J Oncol; 2010 Nov; 37(5):1177-85. PubMed ID: 20878065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Triptolide induces oxidative stress and apoptosis and activates PIK3/Akt signaling pathway in TM4 sertoli cells].
    Wang H; Chen L; Ye XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):607-612. PubMed ID: 30122757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis.
    Hu H; Huang G; Wang H; Li X; Wang X; Feng Y; Tan B; Chen T
    Oncol Rep; 2018 Mar; 39(3):1191-1196. PubMed ID: 29286149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
    Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.
    Zhao H; Shi P; Deng M; Jiang Z; Li Y; Kannappan V; Wang W; Li P; Xu B
    Oncotarget; 2016 Dec; 7(51):85515-85528. PubMed ID: 27888802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.
    Cheng X; Shi W; Zhao C; Zhang D; Liang P; Wang G; Lu L
    Mol Med Rep; 2016 Apr; 13(4):3257-64. PubMed ID: 26935527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.
    Zhou H; Guo W; Long C; Wang H; Wang J; Sun X
    Biochem Biophys Res Commun; 2015 Jan; 456(3):815-20. PubMed ID: 25511707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells.
    Miyata Y; Sato T; Ito A
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1081-6. PubMed ID: 16176806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
    Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
    Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effect of triptolide on glioblastoma multiforme in vitro.
    Lin J; Chen L; Lin Z; Zhao M
    J Int Med Res; 2007; 35(4):490-6. PubMed ID: 17697526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
    Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
    Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.